Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Summary of financial results for the 1st quarter of the fiscal year ending May 31, 2019 [Japanese GAAP] (consolidated)
Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Interim report
Pharmarise Holdings: Confirmatory letter.
Pharmarise Holdings: Financial Report - 38th Term (2023/06/01 - 2024/05/31)
Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Announcement regarding the dividends of surplus funds.
Pharmarise Holdings: Announcement of differences between financial estimates and actual results for the entire fiscal year of May Heisei 6
Pharmarise Holdings: FY May 2024 financial results announcement (Japan GAAP) (Consolidated)
Pharmarise Holdings: Announcements of individual stocks regarding the revision of the forecasted financial estimates for the full fiscal year ending May 2024 and recording of special losses.
Pharmarize Holdings: Confirmation
Pharmarize Holdings: Quarterly Report - 38th Quarter (2023/12/01 - 2024/02/29)
Pharmarise Holdings: Notice regarding revisions to the full-year consolidated earnings forecast for the fiscal year ending May 31, 2020
Pharmarise Holdings: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending May 31, 2020 [Japanese GAAP] (Consolidated)
Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Confirmation letter
Pharmarise Holdings: Quarterly Report - 38th Quarter 2 (2023/09/01 to 2023/11/30)
Pharmarise Holdings: Brief Financial Report for the 2nd Quarter Ending May 31, 2020 [Japanese GAAP] (Consolidated)
Pharmarise Holdings: Extraordinary Report
No Data
No Data